Vectus Biosystems Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: 2.572x

Vectus Biosystems Ltd cash flow conversion efficiency. Based on the latest financial reports, Vectus Biosystems Ltd (VBS) has a cash flow conversion efficiency ratio of 2.572x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-659.98K ≈ $-466.98K USD) by net assets (AU$-256.62K ≈ $-181.58K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Vectus Biosystems Ltd (2012–2025)

Cash flow conversion efficiency of Vectus Biosystems Ltd from 2012 to 2025. This chart illustrates how Vectus Biosystems Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Vectus Biosystems Ltd (VBS) stock price for real-time trading data and today's change.

Vectus Biosystems Ltd Cash Flow Conversion Ratio Explained

Vectus Biosystems Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Vectus Biosystems Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vectus Biosystems Ltd ranked by their cash flow conversion efficiency. Also see VBS market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Mid Wynd International Investment Trust plc LSE:MWY	0.002x
MacKenzie Realty Capital, Inc. Common Stock NASDAQ:MKZR	-0.007x
SATO Technologies Corp V:SATO	-0.336x
Hansa Trust LSE:HAN	0.324x
Copper Lake Resources Ltd V:CPL	-0.092x
Sylvania Platinum Limited LSE:SLP	0.095x
Pheton Holdings Ltd Class A Ordinary Shares NASDAQ:PTHL	-0.599x
Empire Metals Limited LSE:EEE	-0.098x

Annual Cash Flow Conversion Efficiency for Vectus Biosystems Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Vectus Biosystems Ltd from 2012 to 2025. Review Vectus Biosystems Ltd leverage flexibility ratio to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-256.62K ≈ $-181.58K	AU$-830.09K ≈ $-587.34K	3.235x	+336.52%
2024-06-30	AU$1.49 Million ≈ $1.05 Million	AU$-2.03 Million ≈ $-1.44 Million	-1.368x	-104.82%
2023-06-30	AU$3.52 Million ≈ $2.49 Million	AU$-2.35 Million ≈ $-1.66 Million	-0.668x	-166.48%
2022-06-30	AU$-4.42 Million ≈ $-3.13 Million	AU$-4.44 Million ≈ $-3.14 Million	1.004x	-10.54%
2021-06-30	AU$-2.90 Million ≈ $-2.05 Million	AU$-3.26 Million ≈ $-2.30 Million	1.123x	+151.03%
2020-06-30	AU$-6.71 Million ≈ $-4.75 Million	AU$-3.00 Million ≈ $-2.12 Million	0.447x	+60.32%
2019-06-30	AU$-3.73 Million ≈ $-2.64 Million	AU$-1.04 Million ≈ $-736.30K	0.279x	-54.62%
2018-06-30	AU$-2.26 Million ≈ $-1.60 Million	AU$-1.39 Million ≈ $-981.46K	0.615x	+101.84%
2017-06-30	AU$116.56K ≈ $82.48K	AU$-3.89 Million ≈ $-2.75 Million	-33.399x	-4696.01%
2016-06-30	AU$3.75 Million ≈ $2.65 Million	AU$-2.61 Million ≈ $-1.85 Million	-0.696x	-376.09%
2015-06-30	AU$11.22 Million ≈ $7.94 Million	AU$-1.64 Million ≈ $-1.16 Million	-0.146x	+99.37%
2014-06-30	AU$55.53K ≈ $39.29K	AU$-1.29 Million ≈ $-915.18K	-23.292x	-1926.15%
2013-06-30	AU$976.04K ≈ $690.61K	AU$-1.12 Million ≈ $-793.92K	-1.150x	-141.21%
2012-06-30	AU$-504.57K ≈ $-357.02K	AU$-1.41 Million ≈ $-995.86K	2.789x	--

About Vectus Biosystems Ltd

AU:VBS Australia Biotechnology

Market Cap

$2.65 Million

AU$3.74 Million AUD

Market Cap Rank

#29633 Global

#1672 in Australia

Share Price

AU$0.07

Change (1 day)

-6.67%

52-Week Range

AU$0.07 - AU$0.44

All Time High

AU$2.00